Intranasal delivery of biologics to the central nervous system.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2012-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.addr.2011.11.002PMID 22119441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nasal drug delivery

  2012cited by this paper
• Microbes' roadmap to neurons

  2011cited by this paper
• Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

  2011cited by this paper
• Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice

  2011cited by this paper
• Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia

  2011influential reference
• The Rostral Migratory Stream Plays a Key Role in Intranasal Delivery of Drugs into the CNS

  2011cited by this paper
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011cited by this paper
• Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain.

  2011cited by this paper
• Chronic Intranasal Treatment with an Anti-Aβ30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

  2011cited by this paper
• Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope.

  2010cited by this paper
• Intranasal delivery of calcitonin gene-related peptide reduces cerebral vasospasm in rats.

  2010cited by this paper
• Erythropoietin plus insulin‐like growth factor‐I protects against neuronal damage in a murine model of human immunodeficiency virus‐associated neurocognitive disorders

  2010cited by this paper
• Intranasal Administration of Nerve Growth Factor Produces Antidepressant-Like Effects in Animals

  2010cited by this paper
• Intranasal Insulin Enhances Postprandial Thermogenesis and Lowers Postprandial Serum Insulin Levels in Healthy Men

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans.

  2010cited by this paper
• Effect of Antibodies to Glutamate on Retention of Conditioned Passive Avoidance Response in Rats with Ischemic Injury of the Prefrontal Cortex

  2010influential reference
• Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder

  2010cited by this paper
• Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS

  2010cited by this paper
• Antiamnestic Effects of Antibodies to Glutamate in Experimental Alzheimer’s Disease

  2010influential reference
• Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

  2010cited by this paper
• Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.

  2010cited by this paper
• Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

  2010cited by this paper
• Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage

  2010cited by this paper
• Intranasal delivery of ESBA105, a TNF-alpha-inhibitory scFv antibody fragment to the brain.

  2009cited by this paper
• Calcium store‐mediated signaling in sustentacular cells of the mouse olfactory epithelium

  2009cited by this paper
• The Cytology of Metastatic Angiosarcoma in Pleural Fluid - A Case Report -

  2009cited by this paper
• NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.

  2009cited by this paper
• The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.

  2009cited by this paper
• Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.

  2009cited by this paper
• Characteristics of compounds that cross the blood-brain barrier

  2009cited by this paper
• Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats.

  2009cited by this paper
• Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory Behaviors

  2009cited by this paper
• Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy

  2009cited by this paper
• Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system.

  2009cited by this paper
• Direct transport of VEGF from the nasal cavity to brain.

  2009cited by this paper
• Intranasal delivery of cells to the brain.

  2009cited by this paper
• Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

  2008cited by this paper
• Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin.

  2008cited by this paper
• Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia.

  2008cited by this paper
• Molecular composition of tight and adherens junctions in the rat olfactory epithelium and fila

  2008cited by this paper
• The blood-brain barrier: connecting the gut and the brain.

  2008cited by this paper
• Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins

  2008cited by this paper
• Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat

  2008cited by this paper
• Delivery of interferon-beta to the monkey nervous system following intranasal administration.

  2008cited by this paper
• Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia.

  2008cited by this paper
• Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents.

  2008cited by this paper
• Intranasal insulin improves cognition and modulates β-amyloid in early AD

  2008cited by this paper
• The olfactory vector hypothesis of neurodegenerative disease: Is it viable?

  2008cited by this paper
• Horizontal Basal Cells Are Multipotent Progenitors in Normal and Injured Adult Olfactory Epithelium

  2008cited by this paper
• Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone

  2008cited by this paper
• Strategies to advance translational research into brain barriers.

  2008cited by this paper
• Oxytocin improves "mind-reading" in humans.

  2007cited by this paper
• Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

  2007cited by this paper
• Systemic and Nasal Delivery of Orexin-A (Hypocretin-1) Reduces the Effects of Sleep Deprivation on Cognitive Performance in Nonhuman Primates

  2007cited by this paper
• Cognitive impairments in the STOP null mouse model of schizophrenia.

  2007cited by this paper
• The role of erythropoietin in neuroprotection: therapeutic perspectives.

  2007cited by this paper
• Intranasally delivered TGF-beta1 enters brain and regulates gene expressions of its receptors in rats.

  2007cited by this paper
• Intranasal delivery: physicochemical and therapeutic aspects.

  2007cited by this paper
• Drug Transport in the Brain

  2006cited by this paper
• Brain uptake of intranasally applied radioiodinated leptin in Wistar rats.

  2006cited by this paper
• Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy

  2006cited by this paper
• Head and Neuroanatomy

  2006cited by this paper
• In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space.

  2006cited by this paper
• Mechanisms to explain the reverse perivascular transport of solutes out of the brain.

  2006cited by this paper
• The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

  2006cited by this paper
• Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice.

  2006cited by this paper
• Overweight humans are resistant to the weight-reducing effects of melanocortin4-10.

  2006cited by this paper
• The Nose Revisited: A Brief Review of the Comparative Structure, Function, and Toxicologic Pathology of the Nasal Epithelium

  2006influential reference
• The role of insulin receptor signaling in the brain.

  2005cited by this paper
• Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice.

  2005cited by this paper
• Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

  2005cited by this paper
• Inhibition of appetite by nasal leptin administration in rats

  2005cited by this paper
• Olfactory ensheathing cells and olfactory nerve fibroblasts maintain continuous open channels for regrowth of olfactory nerve fibres

  2005cited by this paper
• Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.

  2005cited by this paper
• Oxytocin increases trust in humans

  2005cited by this paper
• Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging.

  2004cited by this paper
• The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats.

  2004cited by this paper
• Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.

  2004cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat

  2004cited by this paper
• Are the extracellular [correction of extracelluar] pathways a conduit for the delivery of therapeutics to the brain?

  2004cited by this paper
• Central nervous and metabolic effects of intranasally applied leptin.

  2004cited by this paper
• Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.

  2004cited by this paper
• Intranasal insulin improves memory in humans.

  2004cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Are the Extracellular Pathways a Conduit for the Delivery of Therapeutics to the Brain

  2004cited by this paper
• Freeze-fracture and tracer experiments on the permeability of the zonulae occludentes in the olfactory mucosa of vertebrates

  2004cited by this paper
• Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal Administration

  2004cited by this paper
• Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species

  2004cited by this paper
• Uptake of exogenous proteins in mouse olfactory cells

  2004cited by this paper
• Anatomy of the Human Nasal Passages

  2003cited by this paper
• Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible.

  2003cited by this paper
• Arterial Pulsation-driven Cerebrospinal Fluid Flow in the Perivascular Space: A Computational Model

  2003cited by this paper
• A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse.

  2003cited by this paper
• Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

  2003cited by this paper
• Ensheathment of the olfactory nerves in the adult rat

  2003cited by this paper
• The Olfactory System and the Nasal Mucosa as Portals of Entry of Viruses, Drugs, and Other Exogenous Agents into the Brain

  2003cited by this paper
• Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress.

  2003cited by this paper
• Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran

  2002cited by this paper

• Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases.

  2026cites this paper
• Unravelling Nanotherapeutics for Treatment of Neuroinfectious Diseases

  2026cites this paper
• Hypothalamic wars: the last nanodelivery.

  2026cites this paper
• Trans-septal delivery of hydrogel-encapsulated human umbilical cord MSC-derived neurospheres for acute neuroprotection in traumatic brain injury

  2026cites this paper
• Overcoming intranasal delivery barriers with ultrastable polyzwitterionic siRNA nanocages for enhanced glioblastoma therapy

  2026cites this paper
• Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain

  2026cites this paper
• L17E cell-penetrating peptide enhances intranasal delivery of IgG to the cerebrospinal fluid in mice.

  2026cites this paper
• Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy.

  2026cites this paper
• Intranasal Delivery of Natural Compounds: A Promising approach for Parkinson’s Disease therapy

  2026cites this paper
• Nasal hormone administration can support ambystomid salamander ex-situ conservation breeding programs

  2026cites this paper
• A critical comparative insight on nanocarrier-based intranasal delivery of statins for neuroprotective applications.

  2026cites this paper
• Molecular insights, challenges and progressions of polysaccharide and protein-based biopolymeric carriers for intranasal drug delivery: A review.

  2026cites this paper
• Intranasal Drug Delivery in Neuropharmacology: Advances in Brain-Targeted Therapies and Bioethical Challenges

  2026cites this paper
• Lumbrokinase modulates tissue plasminogen activator and alleviates behavioral and cognitive deficits in mice with chronic social defeat stress.

  2026cites this paper
• Chitosan-Modified Biodegradable Polymeric Nanoparticles for Tunable Cannabidiol Release and Enhanced Mucosal Transport

  2026cites this paper
• Targeted Lithium Delivery Via Nasal Gel: Improving Efficacy and Safety in Bipolar Disorder Therapy

  2026cites this paper
• Treatment with Interleukin-17 A antibody restored behavioral and neuronal biomarkers in Amyloid-beta1-42-exposed model of Alzheimer's disease.

  2026cites this paper
• Intranasal delivery of biotherapeutics utilizing nanocarriers: Advancements in surface engineering, clinical progress and the incorporation of artificial intelligence

  2026cites this paper
• Intranasal biomimetic vesicle platform reprograms the glioblastoma microenvironment for enhanced immunotherapy

  2026cites this paper
• The phoenixin-14/GPR173 Axis enhances post-stroke angiogenesis through ETS1-mediated VEGF signaling.

  2026cites this paper
• From gut to brain: formulation and transporter-guided approaches to maximise rutin central nervous system delivery.

  2026cites this paper
• New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders

  2026cites this paper
• Frontiers in neurodegeneration: Biomolecular triggers, diagnostic biomarkers, and smart nanotherapeutics

  2026cites this paper
• Multifunctional approaches of cubosome-integrated thermoresponsive gels for intranasal brain targeting: Innovations, therapeutic potential, and challenges

  2026cites this paper
• A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery

  2026influential citation
• Exploring the role of extracellular vesicles in otorhinolaryngology: From diagnostics to therapeutic potential.

  2026cites this paper
• Construction of an Asian Standardized Nasal Cavity Model via Image Registration for Computational Analysis of Drug Particle Deposition

  2026cites this paper
• Intranasal Diazepam Outperforms Midazolam and Lorazepam in Early Seizure Control in Pilocarpine-Induced Mice Model.

  2026cites this paper
• EMERGING NOSE-TO-BRAIN DRUG DELIVERY STRATEGIES FOR AMYOTROPHIC LATERAL SCLEROSIS: A PROMISING FRONTIER IN NEUROTHERAPEUTICS

  2026cites this paper
• Golgi Fragmentation as a Potential Link Between SARS-CoV-2 Infection and Alzheimer's Disease: Mechanisms and Implications for Neurodegeneration in Long COVID.

  2026cites this paper
• Focused ultrasound-enhanced nose-to-brain delivery of a therapeutic antibody in a large-animal model

  2026cites this paper
• Hesperetin alleviates neuronal pyroptosis by promoting mitophagy via DHCR24/BACE1 signaling pathway after subarachnoid hemorrhage in mice

  2026cites this paper
• Microvascular Failure in the Aging Brain: Converging Pathways of Oxidative Stress, Inflammation, and Endothelial Decline

  2026cites this paper
• Challenges and strategies for nose-to-brain delivery in treating neurological disorders

  2025cites this paper
• Brain on the mend: induced mesenchymal stem cell-based therapies promote functional recovery in rats with neonatal hypoxic-ischemic brain injury.

  2025cites this paper
• How can we optimize the delivery of IL-2 to traumatic brain injury patients?

  2025cites this paper
• Optimization of Eudragit RS100 Nanocapsule Formulation for Encapsulating Perillyl Alcohol and Temozolomide Using Design of Experiments

  2025cites this paper
• Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models

  2025cites this paper
• Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution

  2025cites this paper
• Navigating the challenges in pediatric intranasal drug delivery

  2025cites this paper
• Intranasal delivery of extracellular vesicles: A promising new approach for treating neurological and respiratory disorders.

  2025cites this paper
• A fluid and particle mechanics perspective of nasal drug delivery

  2025cites this paper
• Hormonal induction of spermiation in the common eastern froglet: testing alternative routes of hormone administration

  2025cites this paper
• Intranasal Aβ1−42 Exposure Led To Neurobehavioral Alteration, Neuroinflammatory and Neurodegenerative Molecular Biomarkers in Mice Brain

  2025influential citation
• Nasal Staphylococcus aureus carriage promotes depressive behaviour in mice via sex hormone degradation

  2025cites this paper
• Therapeutic potential of small peptides in Alzheimer's disease: Advances in memory restoration and targeted delivery systems.

  2025cites this paper
• Characterization of an olfactory system dysfunction model: a vanadium dose-effect study via nose-to-brain delivery in rats

  2025cites this paper
• Mesenchymal stromal cell extracellular vesicles as immune modulators and drug carriers in neurodegenerative disorders.

  2025cites this paper
• Improving nasal spray deposition: advances and strategies to overcome anatomical and physiological barriers

  2025influential citation
• Therapeutic potential of chrysin in regulation of interleukin-17 signaling in a repeated intranasal amyloid-beta-induced Alzheimer's disease model.

  2025cites this paper
• Albumin antagonizes Alzheimer's disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation.

  2025cites this paper
• Brain–Bone Axis in Physiological and Pathological Conditions

  2025cites this paper
• Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights

  2025cites this paper
• Intranasal amyloid model of Alzheimer’s disease - potential opportunities and challenges

  2025cites this paper
• Delivery of drugs through the blood-brain barrier: need for trials.

  2025cites this paper
• Polysaccharides: New Frontiers for Nasal Administration of Medicines

  2025cites this paper
• Intranasal Administrations of AP39-Loaded Liposomes Selectively Deliver H2S to Neuronal Mitochondria to Protect Neonatal Hypoxia-Ischemia by Targeting ERK1/2 and Caspase-1.

  2025cites this paper
• Development of a predictive model for pediatric intranasal drug delivery with nasal sprays: Leveraging intersubject variability in anatomical dimensions, administration-related parameters, and airway patency

  2025cites this paper
• Low-Intensity Ultrasound Facilitation of Intranasal Drug Delivery to Olfactory Bulb and Trigeminal Nerves.

  2025cites this paper
• Mechanistic role of proteins and peptides in Management of Neurodegenerative Disorders.

  2025cites this paper
• The influence of barrier discharge by microplasma drug delivery system probe on cell viability and intracellular drug absorption

  2025cites this paper
• Research Progress on Nasal Delivery of siRNA Nanocarrier Systems for the Treatment of Neurodegenerative Diseases

  2025cites this paper
• Cell Membrane- and Vesicle-Based Bionic Nanodrugs: Applications in Central Nervous System Diseases and Exploration of Nasal–Cerebral Delivery

  2025cites this paper
• Nanoparticle-Mediated Nose-to-Brain Delivery for Ischemic Stroke Therapy: Preclinical Insights

  2025influential citation
• In-situ Nanolipoidal Gel of Stiripentol for Intranasal Administration: Preclinical Evidence of Enhanced Biopharmaceutical and Therapeutic Outcomes

  2025cites this paper
• Polymeric nanoparticles as a platform for nose-to-brain delivery.

  2025cites this paper
• Nanoemulsions and Microemulsions for Intranasal Drug Delivery: A Bibliometric Analysis and Emerging Trends (2004–2024)

  2025cites this paper
• Potential risks prompted from epicutaneous and intranasal exposure to indoxacarb in rats.

  2025cites this paper
• Polymeric nanoparticles for efficient nose-to-brain delivery.

  2025cites this paper
• Intranasal delivery route for neurodegenerative diseases: recent insights and future directions

  2025cites this paper
• A Single‐Molecule Pleuripotent Scaffold for Combinational Therapy of Alzheimer's Disease via Intranasal Administration

  2025cites this paper
• Nasal Residence Depending on the Administered Dosage Form: Impact of Formulation Type on the In Vivo Nasal Retention Time of Drugs in Rats

  2025cites this paper
• Intranasal delivery of drug-loaded polymeric nanomicelles for brain targeting: a comprehensive review

  2025cites this paper
• Effects of Intranasal Antibodies on Murine Models of Neurological Disorders: A Systematic Review.

  2025cites this paper
• Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories.

  2025cites this paper
• Nasal-to-brain delivery of CCR5 antagonist for reshaping the dysregulated microglia-neuron axis and enhancing post-traumatic cognitive function.

  2025cites this paper
• Absence of Adverse Effects on Pulmonary Histopathology and Functions Following Inhalation Exposure to Chloromethylisothiazolinone/Methylisothiazolinone

  2025cites this paper
• Olfactory Drug Delivery in Rodents: Deposition and Pharmacokinetics.

  2025cites this paper
• Formulation, sterilization, and clinical evaluation of microneedles for vaccine and biologic delivery: A review.

  2025cites this paper
• First‐in‐human positron emission tomography study of intranasal insulin in aging and MCI

  2025cites this paper
• FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems

  2025cites this paper
• The Application of Ultrasound-Induced Blood-Brain Barrier Opening in Neurology and Immunology.

  2025cites this paper
• Intranasal Drug Delivery Technology in the Treatment of Central Nervous System Diseases: Challenges, Advances, and Future Research Directions

  2025cites this paper
• Exosome-based mucosal therapeutic and diagnostic system: towards clinical translation.

  2025cites this paper
• Emerging Targeted Delivery Strategies of Nanosystems for Ischemic Stroke Treatment

  2025cites this paper
• Framework Nucleic Acid Nanomaterials for Central Nervous System Therapies: Design for Barrier Penetration, Targeted Delivery, Cellular Uptake, and Endosomal Escape.

  2025cites this paper
• ORAL OR INTRANASAL ANGIOTENSIN-(1-7) IMPROVES ANXIETY AND DEPRESSION-LIKE BEHAVIORS IN MICE SUBJECTED TO ALLERGIC PULMONARY INFLAMMATION.

  2025cites this paper
• Recombinant human alpha-N-acetylglucosamine-6-sulfatase delivered to Sanfilippo D mice with repeated intracerebroventricular injections corrects CNS pathology

  2025cites this paper
• Intranasal iron administration induces iron deposition, immunoactivation, and cell-specific vulnerability in the olfactory bulb of C57BL/6 mice

  2025cites this paper
• Nasal Nanotherapeutics for Central Nervous System Disorders: Bridging the Translational Gap in Central Nervous System Drug Delivery.

  2025cites this paper
• Nose-to-brain delivery of biomineralized silk fibroin nanoparticles synergistically extinguish neuroinflammation for efficient depressive-like symptoms alleviation.

  2025cites this paper
• Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease.

  2025cites this paper
• Natural polysaccharides in colloidal drug delivery systems for brain glioma therapy: Mechanisms and advancements.

  2025cites this paper
• Nanoparticles Navigating the Intranasal Route: Innovative Approaches in Neurodegenerative Diseases

  2025influential citation
• How does oxytocin modulate human behavior?

  2025cites this paper
• Review on Air Pollution and Children’s Health

  2025cites this paper
• Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders

  2025influential citation
• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery

  2025influential citation
• [Development of Drug Delivery Systems Based on New Concepts].

  2025cites this paper